Artist’s rendering shows X-rays striking radioluminescent nanoparticles in the brain, which emit red light that triggers a sodium (Na+) and potassium (K+) ion influx and thereby activates brain neurons.
CREDIT : (Image by Zhaowei Chen/Argonne National Laboratory.)
Scientists make pivotal discovery of method for wireless modulation of neurons with X-rays that could improve the lives of patients with brain disorders. The X-ray source only requires a machine like that found in a dentist’s office.
Many people worldwide suffer from movement-related brain disorders. Epilepsy accounts for more than 50 million; essential tremor, 40 million; and Parkinson’s disease, 10 million.
Relief for some brain disorder sufferers may one day be on the way in the form of a new treatment invented by researchers from the U.S. Department of Energy’s (DOE) Argonne National Laboratory and four universities. The treatment is based on breakthroughs in both optics and genetics. It would be applicable to not only movement-related brain disorders, but also chronic depression and pain.
“Our high precision noninvasive approach could become routine with the use of a small X-ray machine, the kind commonly found in every dental office.” — Elena Rozhkova, a nanoscientist in Argonne’s Center for Nanoscale Materials
This new treatment involves stimulation of neurons deep within the brain by means of injected nanoparticles that light up when exposed to X-rays (nanoscintillators) and would eliminate an invasive brain surgery currently in use.
“Our high-precision noninvasive approach could become routine with the use of a small X-ray machine, the kind commonly found in every dental office,” said Elena Rozhkova, a lead author and a nanoscientist in Argonne’s Center for Nanoscale Materials (CNM), a DOE Office of Science User Facility.
Traditional deep brain stimulation requires an invasive neurosurgical procedure for disorders when conventional drug therapy is not an option. In the traditional procedure, approved by the U.S. Food and Drug Administration, surgeons implant a calibrated pulse generator under the skin (similar to a pacemaker). They then connect it with an insulated extension cord to electrodes inserted into a specific area of the brain to stimulate the surrounding neurons and regulate abnormal impulses.
“The Spanish-American scientist José Manuel Rodríguez Delgado famously demonstrated deep brain stimulation in a bullring in the 1960s,” said Vassiliy Tsytsarev, a neurobiologist from the University of Maryland and a co-author of the study. “He brought a raging bull charging at him to a standstill by sending a radio signal to an implanted electrode.”
About 15 years ago, scientists introduced a revolutionary neuromodulation technology, “optogenetics,” which relies on genetic modification of specific neurons in the brain. These neurons create a light-sensitive ion channel in the brain and, thereby, fire in response to external laser light. This approach, however, requires very thin fiberoptic wires implanted in the brain and suffers from the limited penetration depth of the laser light through biological tissues.
The team’s alternative optogenetics approach uses nanoscintillators injected in the brain, bypassing implantable electrodes or fiberoptic wires. Instead of lasers, they substitute X-rays because of their greater ability to pass through biological tissue barriers.
“The injected nanoparticles absorb the X-ray energy and convert it into red light, which has significantly greater penetration depth than blue light,” said Zhaowei Chen, former CNM postdoctoral fellow.
“Thus, the nanoparticles serve as an internal light source that makes our method work without a wire or electrode,” added Rozhkova. Since the team’s approach can both stimulate and quell targeted small areas, Rozhkova noted, it has other applications than brain disorders. For example, it could be applicable to heart problems and other damaged muscles.
One of the team’s keys to success was the collaboration between two of the world-class facilities at Argonne: CNM and Argonne’s Advanced Photon Source (APS), a DOE Office of Science User Facility. The work at these facilities began with the synthesis and multi-tool characterization of the nanoscintillators. In particular, the X-ray excited optical luminescence of the nanoparticle samples was determined at an APS beamline (20-BM). The results showed that the particles were extremely stable over months and upon repeated exposure to the high-intensity X-rays.
According to Zou Finfrock, a staff scientist at the APS 20-BM beamline and Canadian Light Source, “They kept glowing a beautiful orange-red light.”
Next, Argonne sent CNM-prepared nanoscintillators to the University of Maryland for tests in mice. The team at University of Maryland performed these tests over two months with a small portable X-ray machine. The results proved that the procedure worked as planned. Mice whose brains had been genetically modified to react to red light responded to the X-ray pulses with brain waves recorded on an electroencephalogram.
Finally, the University of Maryland team sent the animal brains for characterization using X-ray fluorescence microscopy performed by Argonne scientists. This analysis was performed by Olga Antipova on the Microprobe beamline (2-ID-E) at APS and by Zhonghou Cai on the Hard X-ray Nanoprobe (26-ID) jointly operated by CNM and APS.
This multi-instrument arrangement made it possible to see tiny particles residing in the complex environment of the brain tissue with a super-resolution of dozens of nanometers. It also allowed visualizing neurons near and far from the injection site on a microscale. The results proved that the nanoscintillators are chemically and biologically stable. They do not wander from the injection site or degrade.
“Sample preparation is extremely important in these types of biological analysis,” said Antipova, a physicist in the X-ray Science Division (XSD) at the APS. Antipova was assisted by Qiaoling Jin and Xueli Liu, who prepared brain sections only a few micrometers thick with jeweler-like accuracy.
“There is an intense level of commercial interest in optogenetics for medical applications,” said Rozhkova. “Although still at the proof-of-concept stage, we predict our patent-pending wireless approach with small X-ray machines should have a bright future.”
Original Article: Shining a healing light on the brain
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Noninvasive deep brain stimulation
- North America Deep Brain Stimulation Marketon August 17, 2021 at 10:40 pm
The size of the North America Deep Brain Stimulation Market is predicted to be growing at a CAGR of 9.86% from 2021 to 2026. Countries of North America covered under this report are the United States, ...
- BrainsWay Hosting Key Opinion Leader Webinar on its Deep TMS™ Therapy for Treating Mental Health Disorderson August 17, 2021 at 10:07 am
Deep TMS is a noninvasive neurostimulation treatment that produces significant results by directly stimulating deeper and broader areas of the brain. It is a well-tolerated and effective treatment ...
- Editorial: Advances in Invasive and Non-invasive Brain Stimulation for Dystonia and Other Hyperkinetic Movement Disorderson August 16, 2021 at 3:08 am
a range of exciting advances in invasive and non-invasive stimulation for hyperkinetic movement disorders are showcased. A review by Tisch and Kumar sprovides an overview of globus pallidus deep brain ...
- Increasing Prevalence of Parkinson’s Disease and Approval and Launch of New Products to Augment Growth of Deep Brain Stimulation Devices Marketon August 15, 2021 at 5:00 pm
Deep brain stimulation is a non-invasive neurosurgical treatment involving the placement of an electronic device called a simulator that emits electronic pulses, into the brain. These pulses are ...
- Speech Fluency Improvement in Developmental Stuttering Using Non-invasive Brain Stimulation: Insights From Available Evidenceon August 14, 2021 at 10:32 am
Finally, sporadic reports also describe the single cases of DS that are resulted as incidentally improved in case of using invasive interventions (such as deep brain stimulation ... reviewed studies ...
Go deeper with Google Headlines on:
Noninvasive deep brain stimulation
Go deeper with Bing News on:
Deep brain stimulation
- Dartmouth-Hitchcock neurologist is first in New England -- and one of handful nationally -- to calibrate deep brain stimulation device remotelyon August 20, 2021 at 7:49 am
Hundreds of thousands of Americans live with neurological movement disorders, such as Parkinson's disease. People who live with movement disorders must deal with symptoms like uncontrolled movements, ...
- Neuromodulation for Lennox-Gastaut Syndrome: Interview with Martha Morrell, M.D., CMO of NeuroPaceon August 16, 2021 at 1:36 pm
In a new development, NeuroPace has received $9.3M from the NIH to study the RNS system in the treatment of Lennox-Gastaut Syndrome, a severe form of epilepsy that begins in childhood. The condition ...
- Brain Injury, Ethics, and the Struggle for Consciousnesson August 15, 2021 at 11:04 pm
As the mother of a daughter with severe brain injury and an advocate for patients like her, I found Rights Come to Mind to be a compassionate call to action and a must-read. It should be thoroughly ...
- Restriction of Access to Deep Brain Stimulation for Refractory OCD: Failure to Apply the Federal Parity Acton August 14, 2021 at 11:03 pm
The Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) banned the use of differential rules in the provision of mental health care. In an effort to combat discrimination in health ...
- NeuroOne Medical Technologies' (NMTC) CEO Dave Rosa on Q3 2021 Results - Earnings Call Transcripton August 14, 2021 at 2:11 am
Q3 2021 Earnings Conference Call August 13, 2021 9:00 AM ET Company Participants Dave Rosa – Chief Executive Officer Ron Mcclurg ...